1 January 2020 in Acute Medicine & Surgery
Background: Preventing thrombosis in extracorporeal membrane oxygenation (ECMO) can be life‐saving in cases of coronavirus disease (COVID‐19); however, circuit thrombosis is a complication. This report describes a COVID‐19 patient treated with nafamostat and heparin to prevent circuit thrombosis during ECMO support.Case presentation: A 63‐year‐old man was transferred to our hospital with respiratory failure due to COVID‐19 pneumonia. He was provided venous‐venous ECMO to maintain oxygenation. During ECMO support, occlusive circuit thrombosis developed despite systemic anticoagulation therapy with heparin. He was subsequently given combination therapy with nafamostat and heparin. Although the combination therapy could prevent circuit thrombosis, it was converted to heparin monotherapy because of hyperkalemia and hemothorax. After tracheostomy and a gradual improvement in oxygenation, ECMO was discontinued. He was transferred to another hospital for further rehabilitation.Conclusion: Combination therapy with nafamostat and heparin can prevent circuit thrombosis during ECMO. However, bleeding can still develop with this combination therapy during ECMO.
17 May 2023 in JMIR Rehabilitation and Assistive Technologies
Background: No consensus exists on the efficacy of home-based cardiac rehabilitation (CR) in patients who have undergone transcatheter aortic valve implantation (TAVI). Additionally, there are no reports on home-based cardiac telemonitoring rehabilitation (HBTR) in patients after TAVI. Objective: We aimed to investigate the efficacy of HBTR in patients who have undergone TAVI. Methods: This single-center preliminary study introduced HBTR to patients after TAVI, and the efficacy outcomes of the rehabilitation method were compared to that of a historical control cohort. The historical control cohort (control group) consisted of 6 consecutive patients who underwent ordinary outpatient CR after TAVI from February 2016 to March 2020. Patients who participated in the HBTR program were only recruited after the TAVI procedure and before discharge between April 2021 and May 2022. In the first 2 weeks after TAVI, patients underwent outpatient CR and were trained using telemonitoring rehabilitation systems. Thereafter, patients underwent HBTR twice a week for 12 weeks. The control group performed standard outpatient CR at least once a week for 12 to 16 weeks. Efficacy was assessed using peak oxygen uptake (VO2) prior to and after CR. Results: Eleven patients were included in the HBTR group. All patients underwent 24 HBTR sessions during the 12-week training period, and no adverse events were observed. The control group participants performed 19 (SD 7) sessions during the training period, and no adverse events were observed. Participants in the HBTR and control groups had a mean age of 80.4 (SD 6.0) years and 79.0 (SD 3.9) years, respectively. In the HBTR group, preintervention and postintervention peak VO2 values were 12.0 (SD 1.7) mL/min/kg and 14.3 (SD 2.7) mL/min/kg (P=.03), respectively. The peak VO2 changes in the HBTR and control groups were 2.4 (SD 1.4) mL/min/kg and 1.3 (SD 5.0) mL/min/kg (P=.64), respectively. Conclusions: Home-based CR using a telemonitoring system is a safe outpatient rehabilitation method. Its efficacy is not inferior to that of standard CR in patients who have undergone TAVI. Trial Registration: Japan Registry of Clinical Trials jRCTs032200122; https://jrct.niph.go.jp/latest-detail/jRCTs032200122
16 January 2021 in Journal of Echocardiography
1 February 1992 in SAE International Journal of Advances and Current Practices in Mobility
The adaptation of an active control suspension has remarkably improved the vehicle attitude and ride comfort characteristics. Such an active controlled suspension is controlled by actuators and hydro-dynamic equipments like servo valves. The control strategies are composed of feedback control with each cylinder oil pressure, suspension stroke and velocity. In the practical application of these systems, it must be taken into account that the effect of control is much dependent on the time delay of a controller as well as control elements. The object of this study is to confirm preview effects on the response of the system. The aim of preview feedforward control is to compensate the system delay of active control suspension. The control system is constructed of an ordinary feedback loop and a feedforward loop based on a road preview signal. The control signal from a preview sensor is supplied to an oil control servo valve just before the road preview point arrives at the front tire or the rear one. To confirm the control effects on this control system, calculations based on simulation were executed using a half car model with four degrees of freedom for sprung and unsprung masses. These calculations clarified the control condition that the compensation time range for the decrease of the vertical acceleration of sprung mass exist. Finally, the preview control effects were confirmed experimentally using a test vehicle with an optical preview sensor installed at front bumper. The effectiveness of the preview feedforward control system was verified by the measurement of the vertical acceleration of sprung mass. Compared with a preview controlled vehicle and a non-preview controlled one, the vertical acceleration of the experimental vehicle during on downgrade road driving was decreased by about 25%, and the vertical acceleration in the frequency range from 1 to 8 Hz during on paved rough road driving was decreased by about 30% to 45%.
27 July 2026 in Journal of Cardiac Failure
1 January 2021 in Journal of Coronary Artery Disease
Acute myocardial infarction (AMI) with cardiogenic shock (CS) has poor prognosis, despite using mechanical circulatory support devices. An 85-year-old woman with ST-elevation myocardial infarction (STEMI) was transferred to our hospital. STEMI was caused by plaque rupture of the left main trunk (LMT) along with CS and aborted myocardial damage. She suffered cardiopulmonary arrest despite intra-aortic balloon pumping (IABP) support. Veno-arterial extra corporeal membrane oxygenation (VA-ECMO) and Impella CP were immediately inserted to support the circulation and left ventricular unloading. Then she underwent percutaneous coronary intervention (PCI) and managed to survive. Transthoracic echocardiogram in the subacute phase revealed a preserved left ventricular systolic function though the culprit lesion was in LMT and the area at risk for myocardial infarction was extremely large. Left ventricular unloading using Impella CP could contribute to preservation of cardiac function and diminishing of myocardial damage.